How SGLT2 Inhibitors and GLP1 Agonists are Transforming CKD Care
In this episode of Kidney Health Connections, Dr. Katherine Tuttle, a leading nephrologist and researcher, explores the transformative advancements in chronic kidney disease (CKD) treatment. She discusses the revolutionary impact of SGLT2 inhibitors and GLP1 agonists, which have shifted the landsca…
The FLOW Trial
C. Michael Gibson talks to Katherine Tuttle about semaglutide's positive effects in patients with diabetes and chronic kidney disease.
Save Your Kidneys: What Every Person with Diabetes Needs to Know
Kidney disease often develops quietly and is one of the most serious complications of diabetes. In this episode, we explore why kidney damage is so easy to miss, how early testing can change outcomes, and what actually helps protect kidney health.
You’ll hear practical, hopeful guidance on food, li…
Episode #6: Prevention and Early Intervention for Kidney Disease with Dr. Katherine Tuttle
Robert Rogers: I’m Robert Rogers, host of the Foresight Medicine podcast at the Foresight Medicine Substack where we are envisioning the future of preventive healthcare as a comprehensive whole body framework for leveraging new technology to maintain health as long as possible. In this podcast seri…
Don't Miss a Beat: Finerenone, FIND-CKD, and the Evolution of CKM, with Katherine Tuttle, MD
Check out the video version of this episode on HCPLive!Finerenone's expansion into non-diabetic kidney disease is prompting a broader rethink of how chronic kidney disease is measured, mechanistically understood, and treated across its many causes.
On an episode of Don't Miss a Beat recorded at t…
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME credits: 0.25
Valid until: 14-07-2027
Claim your CME credit at https://reachmd.com/programs/cme/no-patient-with-ckd-left-behind-new-horizons-in-patients-with-ckd-regardless-of-diabetes-status/49260/
A growing body of evidence presented at ERA 2026 is reshaping the conversation around …
The What, Who, When and Why of Screening of UACR
In this first episode of The Increasing Role of Urine Albumin-Creatinine Ratio (UACR) in Cardiovascular Care series, Dr. Ankeet Bhatt interviews Dr. Katherine Tuttle on UACR, its role in kidney disease, and the importance of screening. Listen to Dr. Tuttle provide an overview of the most recent evi…
Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!
With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clini…
Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more!
With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clini…
Renal Outcomes and Cardiorenal Mechanisms in Type 2 Diabetes: Highlights from the FLOW and ACHIEVE-4 Trials - report from EASD 2026
Dr. Katherine Tuttle presents key insights on cardiorenal protection in type 2 diabetes at the EASD 2026 Congress, drawing from both the FLOW and ACHIEVE-4 trials. This brief highlights novel proteomic biomarker analyses explaining the pathways of kidney protection in FLOW, alongside clinical data …
팟캐스트 검색 엔진
당사 웹사이트를 사용하여3,829,722팟캐스트 및196,544,161에피소드를 사람, 장소 또는 주제별로 검색할 수 있습니다.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
